113 related articles for article (PubMed ID: 38253021)
21. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma.
Lu C; Wei Y; Wang X; Zhang Z; Yin J; Li W; Chen L; Lyu X; Shi Z; Yan W; You Y
Mol Cancer; 2020 Feb; 19(1):28. PubMed ID: 32039732
[TBL] [Abstract][Full Text] [Related]
22. LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma.
Teng F; Zhang JX; Chang QM; Wu XB; Tang WG; Wang JF; Feng JF; Zhang ZP; Hu ZQ
J Exp Clin Cancer Res; 2020 Nov; 39(1):235. PubMed ID: 33168027
[TBL] [Abstract][Full Text] [Related]
23. PKMYT1: A Potential Target for CCNE1 Amplificated Colorectal Tumors.
Fang Y; Zhang X; Guo Y; Dong Y; Liu W; Hu X; Li X; Gao D
Cell Biochem Biophys; 2023 Sep; 81(3):569-576. PubMed ID: 37572218
[TBL] [Abstract][Full Text] [Related]
24. PKMYT1 promoted the growth and motility of hepatocellular carcinoma cells by activating beta-catenin/TCF signaling.
Liu L; Wu J; Wang S; Luo X; Du Y; Huang D; Gu D; Zhang F
Exp Cell Res; 2017 Sep; 358(2):209-216. PubMed ID: 28648520
[TBL] [Abstract][Full Text] [Related]
25. MiR-10b inhibits migration and invasion of pancreatic ductal adenocarcinoma via regulating E2F7.
Xu C; Qi X
J Clin Lab Anal; 2020 Oct; 34(10):e23442. PubMed ID: 32592206
[TBL] [Abstract][Full Text] [Related]
26. Targeted regulation of miR-195 on MAP2K1 for suppressing ADM drug resistance in prostate cancer cells.
Zhang JY; Li YN; Mu X; Pan ZL; Liu WB
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8599-8608. PubMed ID: 30575899
[TBL] [Abstract][Full Text] [Related]
27. Protein kinase, membrane‑associated tyrosine/threonine 1 is associated with the progression of colorectal cancer.
Jeong D; Kim H; Kim D; Ban S; Oh S; Ji S; Kang D; Lee H; Ahn TS; Kim HJ; Bae SB; Lee MS; Kim CJ; Kwon HY; Baek MJ
Oncol Rep; 2018 Jun; 39(6):2829-2836. PubMed ID: 29658598
[TBL] [Abstract][Full Text] [Related]
28. A novel E2F/sphingosine kinase 1 axis regulates anthracycline response in squamous cell carcinoma.
Hazar-Rethinam M; de Long LM; Gannon OM; Topkas E; Boros S; Vargas AC; Dzienis M; Mukhopadhyay P; Simpson F; Endo-Munoz L; Saunders NA
Clin Cancer Res; 2015 Jan; 21(2):417-27. PubMed ID: 25411162
[TBL] [Abstract][Full Text] [Related]
29. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.
Zhou J; Chen Q
FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232
[TBL] [Abstract][Full Text] [Related]
30. lncRNA ENST00000585827 Contributes to the Progression of Endometrial Carcinoma via Regulating miR-424/E2F6/E2F7 Axis.
Fang D; Zhang Q; Mu M; Deng Q; Wang Y; Li Q
Appl Biochem Biotechnol; 2023 May; 195(5):3096-3108. PubMed ID: 36525235
[TBL] [Abstract][Full Text] [Related]
31. High Expression of PKMYT1 Predicts Poor Prognosis and Aggravates the Progression of Osteosarcoma
Lu Y; Li P; Zhou Y; Zhang J
Curr Cancer Drug Targets; 2023; 23(6):496-504. PubMed ID: 36748214
[TBL] [Abstract][Full Text] [Related]
32. KDM2B mediates the Wnt/β-catenin pathway through transcriptional activation of PKMYT1 via microRNA-let-7b-5p/EZH2 to affect the development of non-small cell lung cancer.
Zhang X; Yin Z; Li C; Nie L; Chen K
Exp Cell Res; 2022 Aug; 417(2):113208. PubMed ID: 35580699
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-302a/d inhibits the self-renewal capability and cell cycle entry of liver cancer stem cells by targeting the E2F7/AKT axis.
Ma YS; Lv ZW; Yu F; Chang ZY; Cong XL; Zhong XM; Lu GX; Zhu J; Fu D
J Exp Clin Cancer Res; 2018 Oct; 37(1):252. PubMed ID: 30326936
[TBL] [Abstract][Full Text] [Related]
34. Knockdown of PKMYT1 is associated with autophagy inhibition and apoptosis induction and suppresses tumor progression in hepatocellular carcinoma.
Wu F; Tu C; Zhang K; Che H; Lin Q; Li Z; Zhou Q; Tang B; Yang Y; Chen M; Shao C
Biochem Biophys Res Commun; 2023 Jan; 640():173-182. PubMed ID: 36512849
[TBL] [Abstract][Full Text] [Related]
35. PKMYT1 Promotes Gastric Cancer Cell Proliferation and Apoptosis Resistance.
Zhang QY; Chen XQ; Liu XC; Wu DM
Onco Targets Ther; 2020; 13():7747-7757. PubMed ID: 32801781
[TBL] [Abstract][Full Text] [Related]
36. E2F7-EZH2 axis regulates PTEN/AKT/mTOR signalling and glioblastoma progression.
Yang R; Wang M; Zhang G; Bao Y; Wu Y; Li X; Yang W; Cui H
Br J Cancer; 2020 Oct; 123(9):1445-1455. PubMed ID: 32814835
[TBL] [Abstract][Full Text] [Related]
37. miR-132 Regulates Adriamycin Resistance in Colorectal Cancer Cells Through Targeting Extracellular Signal-Regulated Kinase 1.
Liu Y; Zhang M
Cancer Biother Radiopharm; 2019 Aug; 34(6):398-404. PubMed ID: 30939040
[No Abstract] [Full Text] [Related]
38. Knockdown of circ_0006528 Suppresses Cell Proliferation, Migration, Invasion, and Adriamycin Chemoresistance via Regulating the miR-1236-3p/CHD4 Axis in Breast Cancer.
Hao J; Du X; Lv F; Shi Q
J Surg Res; 2021 Apr; 260():104-115. PubMed ID: 33333383
[TBL] [Abstract][Full Text] [Related]
39. HOXB13 suppresses proliferation, migration and invasion, and promotes apoptosis of gastric cancer cells through transcriptional activation of VGLL4 to inhibit the involvement of TEAD4 in the Hippo signaling pathway.
Geng H; Liu G; Hu J; Li J; Wang D; Zou S; Xu X
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396425
[TBL] [Abstract][Full Text] [Related]
40. Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification.
Hu Y; Gong C; Li Z; Liu J; Chen Y; Huang Y; Luo Q; Wang S; Hou Y; Yang S; Xiao Y
Mol Cancer; 2022 Feb; 21(1):34. PubMed ID: 35114989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
